What is William Blair’s Forecast for Altimmune Q2 Earnings?
Altimmune, Inc. (NASDAQ:ALT – Free Report) – William Blair increased their Q2 2025 earnings estimates for shares of Altimmune in a note issued to investors on Tuesday, May 13th. William Blair analyst A. Hsieh now forecasts that the company will earn ($0.31) per share for the quarter, up from their prior forecast of ($0.37). William […]
